![IceCure ProSense DMS-7063 Скачать руководство пользователя страница 8](http://html1.mh-extra.com/html/icecure/prosense-dms-7063/prosense-dms-7063_user-manual_3378524008.webp)
IceCure™ Medical Ltd.
DMS-7063 rev. C
ProSense™
Confidential
User Manual
8
US User Manual
OVERVIEW
Introduction
ProSense™
Cryoablation System is a comprehensive system for cryotherapy of human
tissue based on
IceCure™
Medical’s technology. All established cryotherapy techniques
utilize a low temperature cryogen under pressure. The
ProSense™
Cryoablation System
utilizes liquid nitrogen that causes the cryoprobe to reach very low temperatures thereby
freezing tissue with which it comes in contact.
Intended use
ProSense™ cryoablation system is intended for cryogenic destruction of tissue during
s
urgical procedures by the application of extreme cold temperatures. ProSense™
cryoablation system is indicated for use as a cryosurgical tool in the fields of general
surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT,
gynecology, oncology, proctology, and urology. The system is designed to destroy tissue
by the application of extreme cold temperatures including prostate and kidney tissue,
liver metastases, tumors, skin lesions, and warts. ProSense™ cryoablation system may be
used with an ultrasound device to provide real-time visualization of the cryosurgical
procedure.
The system is suitable for use in a number of cryotherapy applications. However, it is
ONLY indicated for use in patients whom the practitioner has deemed eligible for
cryotherapy.
Indications for use
ProSense™ cryoablation system is indicated for use as a cryosurgical tool in the fields of
general surgery, dermatology, thoracic surgery, gynecology, oncology, proctology, and
urology as detailed below. The ProSe
nse™ cryoablation system may be used with an
ultrasound device to provide real-time visualization of the cryosurgical procedure.
•
Urology
- ablate prostate tissue in cases of prostate cancer and benign prostatic
hyperplasia (BPH).
•
Oncology
- ablation of cancerous or malignant tissue and benign tumors and palliative
intervention.
•
Dermatology
- ablation or freezing of skin cancers and other cutaneous disorders.
Palliation of tumors of the skin. Destruction of warts or lesions.
•
Gynecology
- ablation of malignant neoplasia or benign dysplasia of the female genitalia.
•
ENT
Palliation of tumors of the oral cavity and ablation of leukoplakia of the mouth.
•
General Surgery
- ablation of leukoplakia of mouth, angiomas, sebaceous hyperplasia,
basal cell tumors of the eyelid or canthus area, ulcerated basal cell tumors,
dermatofibromas, small hemangiomas, mucocele cysts, multiple warts, plantar warts,
hemorrhoids, anal fissures, perianal condylomata, pilonidal cysts actinic and seborrheic
keratoses, cavernous hemangiomas, recurrent cancerous lesions. Palliation of tumors of